XENON PHARMACEUTICALS INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-33.5% -$15M
$-62M
Free Cash Flow↑+59.4% +$465K
$-318K
Investing Cash Flow↓-36.4% -$36M
$63M
Financing Cash Flow↑+836.0% +$101M
$114M
Capex↓-59.4% -$465K
$318K
Stock-Based Comp↑+3.8% +$516K
$14M
D&A↓-3.5% -$22K
$611K
SBC Allocated Expense↑+3.8% +$516K
$14M
SBC Unrecognized Cost
$121M